Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (151-160 of 485) with videos related to

Pageof 49
Sort By:
Vaccines|February 13, 2021
Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity LostFlorian Zeevat, Evgeni Dvortsin, Abrham Wondimu, et al.
Applied Health Economics and Health Policy|September 4, 2018
Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related HospitalizationsJudith J Gout-Zwart, Erien H J Olde Hengel, Petra Hoogland, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 12, 2011
Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysisMaarten J Postma, Cornelis Boersma, Dominique Vandijck, et al.
Human Vaccines & Immunotherapeutics|July 25, 2013
A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirusYiling Jiang, Aline Gauthier, Maarten J Postma, et al.
Drugs|November 29, 2012
Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysisFolgerdiena M de Vries, Petra Denig, Koen B Pouwels, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 14, 2016
Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the NetherlandsMaartje S Jacobs, Femke Kaasenbrood, Maarten J Postma, et al.
Vaccines|May 24, 2020
Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in IndonesiaAuliya A Suwantika, Neily Zakiyah, Arif S W Kusuma, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 1, 2021
A novel perspective on pharmaceutical R&D costs: opportunities for reductionsSimon van der Schans, Frans De Loos, Cornelis Boersma, et al.
Journal of Global Health|May 25, 2023
Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for IndonesiaAfifah Machlaurin, Jos Luttjeboer, Didik Setiawan, et al.
Vaccine|October 23, 2025
Acceptance and willingness to pay for pneumococcal vaccination in Vietnam: insights into adult preferences and influencing factorsBa Khuong Cao, Thi Phuong Lan Nguyen, Maarten J Postma, et al.
Pageof 49

Showing results (151-160 of 485) with videos related to

Sort By:
Pageof 49
Vaccines|February 13, 2021
Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity LostFlorian Zeevat, Evgeni Dvortsin, Abrham Wondimu, et al.
Applied Health Economics and Health Policy|September 4, 2018
Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related HospitalizationsJudith J Gout-Zwart, Erien H J Olde Hengel, Petra Hoogland, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 12, 2011
Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysisMaarten J Postma, Cornelis Boersma, Dominique Vandijck, et al.
Human Vaccines & Immunotherapeutics|July 25, 2013
A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirusYiling Jiang, Aline Gauthier, Maarten J Postma, et al.
Drugs|November 29, 2012
Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysisFolgerdiena M de Vries, Petra Denig, Koen B Pouwels, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 14, 2016
Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the NetherlandsMaartje S Jacobs, Femke Kaasenbrood, Maarten J Postma, et al.
Vaccines|May 24, 2020
Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in IndonesiaAuliya A Suwantika, Neily Zakiyah, Arif S W Kusuma, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 1, 2021
A novel perspective on pharmaceutical R&D costs: opportunities for reductionsSimon van der Schans, Frans De Loos, Cornelis Boersma, et al.
Journal of Global Health|May 25, 2023
Non-restrictive open vial policy combined with the home visit vaccinations for improving BCG coverage in a high-incidence outreach region: A model-based cost-effectiveness analysis for IndonesiaAfifah Machlaurin, Jos Luttjeboer, Didik Setiawan, et al.
Vaccine|October 23, 2025
Acceptance and willingness to pay for pneumococcal vaccination in Vietnam: insights into adult preferences and influencing factorsBa Khuong Cao, Thi Phuong Lan Nguyen, Maarten J Postma, et al.
Pageof 49